CAR T cells become supercharge when pumped with large doses of a protein that helps them resemble stem cells 🤯 buff.ly/49RJtVM

Small molecule drug discovery can be hard! It's a Friday afternoon but here's where our head is at at Deep Origin 👇 buff.ly/3UCWhLv

We're thrilled to announce Balto, the world's first AI assistant for drug discovery! Balto provides viable hits for drug discovery programs faster, more accurately, and easier than ever before. It's as simple as a conversation. Sign up today 👇 buff.ly/4bc1ShL

Particularly in light of all the #AlphaFold talk, we wanted to spill the beans on what we've been working on 🎉 Read more below 👇 buff.ly/3UQmjuA

With all of the AlphaFold talk over the last few days, we wanted to explore the capabilities ourselves. Garik Petrosyan and Garegin Papoian weigh in after reviewing the publicly available instance and paper 👇 buff.ly/3JXA3xy

Check out Deep Origin's Jonathan Karr on best practices and a hands-on tutorial for building operating systems for hashtag#lifeScience using hashtag#Docker 👇 buff.ly/4apwbju

Keen on computational research but get stuck? Check out our beginner-friendly tutorial on Seurat for many core bioinformatics processes 👇 buff.ly/44Y6FRl

Heading to Bio next week? Kick off your Wednesday with our Future of Drug Discovery breakfast! buff.ly/4565NKx

We received a lot of love for our intro to Seurat - so we updated it to make it even more comprehensive! buff.ly/44Y6FRl

How will AI impact the future of health and longevity? Checkout this recent feature of Deep Origin Co-Founder and CEO as he talks about his days at Oculus VR, investments into life science companies, and why he founded Deep Origin 👇 buff.ly/3z62U0h

Despite breakthrough models of the last year, fundamental challenges stand in the way of leveraging AI for bio. That's why we made our end-to-end platform for life science research. Read more on some of the fundamental problems we're aiming to solve 👇 buff.ly/3LCTNXY

Loved this recent conversation between Arkadi Mazin from Lifespan.io and Deep Origin CEO Michael Antonov on the largest challenges and cutting-edge of #longevity and #drugDiscovery 🙌 buff.ly/3SOcdt3

The Deep Origin OS is growing up! We're thrilled to announce our open beta, which helps life science researchers turn diverse data into insights in minutes. For a limited time we're offering free access to the platform, sign up below 👇 buff.ly/3RenW2o

Much as AlphaFold was made possible due to well-structured and annotated data from the Protein Data Bank, structuring and annotating your own data is critical to enabling your breakthrough discoveries. Join us on September 19th at 11AM PT! buff.ly/4gfMzHt

We've got some exciting news in the works. But first, some backstory on what we've been working on, including what happens when three chemists go on a hike ... 🤖 buff.ly/48ldq1o

What's better than 10x performance of major molecular modeling tools? Getting it into 10x as many hands. That's why we're thrilled to announce Balto. Finally, a useful AI Assistant for drug discovery 👇 buff.ly/4hrFNip

We built one of the most performant molecular modeling algorithms available. How do you magnify 10x improvement even more? Make the tool accessible to a wider audience - empowering medicinal chemists. Get your first month free AND $50 free credit. deeporigin.com/balto-ai-assis…

Near-term utility is a must to achieve the grander vision. As the well-worn modeling adage goes: "all models are wrong, but some are useful." Check out our take on #AI #VirtualCells: buff.ly/3Bdgsc4

Loved The Atlantic's take on the future of the virtual cell. We're one of the teams working on this, and actually just outlined our thoughts on the status, opportunities, and challenges of a virtual cell in this blog post buff.ly/3Bdgsc4 . Spoiler: ML isn't enough.

Didn't get a chance to attend #JPM? Here are our top takeaways for '25 👇 🧪 🤖 buff.ly/42ubeno